Suppr超能文献

人参皂苷Ro通过IBA1/GFAP-MAPK信号通路改善APP/PS1小鼠的认知障碍和神经炎症。

Ginsenoside Ro ameliorates cognitive impairment and neuroinflammation in APP/PS1 mice via the IBA1/GFAP-MAPK signaling pathway.

作者信息

Li Tianyao, Chen Jiaxin, Xie Zhouyuan, Fang Jiansong, Wu Qiqing, Cao Xinyue, Chen Ziying, Wang Yiyun, Fan Qiqi, Wang Qi, Liu Jinman

机构信息

Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.

Affiliated Jiangmen TCM Hospital of Ji'nan University, Jiangmen, China.

出版信息

Front Pharmacol. 2025 Feb 24;16:1528590. doi: 10.3389/fphar.2025.1528590. eCollection 2025.

Abstract

INTRODUCTION

Ginseng, known as the "king of herbs," has long been used in traditional Chinese medicine due to its beneficial properties, including anti-aging, anti-inflammatory, and anti-apoptotic effects. Ginsenosides, the active compounds in ginseng, have shown promise in treating neurodegenerative diseases such as Alzheimer's disease (AD). This study investigates the therapeutic potential of Ginsenoside Ro and its underlying mechanisms in AD treatment.

METHODS

In this study, male APP/PS1 transgenic mice were divided into five groups and treated with Ginsenoside Ro or ginseng for one month. Cognitive function and anxiety were assessed through behavioral tests, including the open field test (OFT) and Morris water maze (MWM). To evaluate Aβ deposition, neuronal apoptosis, neuroinflammation, and the MAPK pathway, various techniques were employed: Thioflavin-T staining, Nissl staining, immunofluorescence, Western blot, and qRT-PCR analyses.

RESULTS

Ginsenoside Ro significantly improved cognitive function and reduced anxiety in APP/PS1 mice. It also decreased Aβ deposition and ameliorated neuronal apoptosis in the cerebral cortex. The treatment regulated the expression of pro-apoptotic proteins (Bax and Caspase3) and increased the anti-apoptotic protein Bcl-2. Additionally, Ginsenoside Ro reduced neuroinflammation by decreasing IBA1-positive microglia and GFAP-positive astrocytes and lowering pro-inflammatory cytokines while enhancing anti-inflammatory cytokine IL-10. Furthermore, the phosphorylation levels of p38 and JNK in the MAPK pathway were significantly reduced, suggesting a key mechanism for its therapeutic effects.

DISCUSSION

These findings provide strong evidence supporting Ginsenoside Ro as a potential therapeutic agent for Alzheimer's disease. Its effects appear to be mediated through the modulation of the IBA1/GFAP-MAPK pathway, which may offer new insights into AD treatment strategies.

摘要

引言

人参被誉为“百草之王”,因其具有抗衰老、抗炎和抗凋亡等有益特性,长期以来一直应用于传统中医。人参中的活性成分人参皂苷在治疗阿尔茨海默病(AD)等神经退行性疾病方面显示出前景。本研究探讨人参皂苷Ro在AD治疗中的治疗潜力及其潜在机制。

方法

在本研究中,雄性APP/PS1转基因小鼠被分为五组,并用人参皂苷Ro或人参治疗一个月。通过行为测试评估认知功能和焦虑,包括旷场试验(OFT)和莫里斯水迷宫(MWM)。为了评估Aβ沉积、神经元凋亡、神经炎症和MAPK途径,采用了各种技术:硫黄素-T染色、尼氏染色、免疫荧光、蛋白质免疫印迹和qRT-PCR分析。

结果

人参皂苷Ro显著改善了APP/PS1小鼠的认知功能并减轻了焦虑。它还减少了大脑皮层中的Aβ沉积并改善了神经元凋亡。该治疗调节了促凋亡蛋白(Bax和Caspase3)的表达并增加了抗凋亡蛋白Bcl-2。此外,人参皂苷Ro通过减少IBA1阳性小胶质细胞和GFAP阳性星形胶质细胞并降低促炎细胞因子,同时增强抗炎细胞因子IL-10来减轻神经炎症。此外,MAPK途径中p38和JNK的磷酸化水平显著降低,这表明了其治疗作用的关键机制。

讨论

这些发现提供了有力证据,支持人参皂苷Ro作为阿尔茨海默病的潜在治疗药物。其作用似乎是通过调节IBA1/GFAP-MAPK途径介导的,这可能为AD治疗策略提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb3/11891224/f54ffa74ed27/fphar-16-1528590-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验